|
|
Blood, 1 November 2007, Vol. 110, No. 9, pp. 3158-3167.
Prepublished online as a Blood First Edition Paper on July 11, 2007; DOI 10.1182/blood-2007-01-066811.
Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes
Cornelia Halin1,
Nadja E. Tobler1,
Benjamin Vigl1,
Lawrence F. Brown2, and
Michael Detmar1
1 Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, Zurich, Switzerland; and
2 Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
Lymphangiogenesis is involved in tumor cell metastasis and plays a major role in chronic inflammatory disorders. To investigate the role of lymphangiogenesis in inflammation, we induced and maintained delayed-type hypersensitivity (DTH) reactions in the ears of mice and then analyzed the resulting lymphangiogenesis in the inflamed tissue and draining lymph nodes (LNs) by quantitative fluorescence-activated cell sorting (FACS) and by immunofluorescence. Long-lasting inflammation induced a significant increase in the number of lymphatic endothelial cells, not only in the inflamed ears but also in the ear-draining auricular LNs. Inflammation-induced lymphangiogenesis was potently blocked by systemic administration of a vascular endothelial growth factor (VEGF)-A neutralizing antibody. Surprisingly, tissue inflammation specifically induced LN lymphangiogenesis but not LN angiogenesis. These findings were explained by analysis of both VEGF-A protein and mRNA levels, which revealed that VEGF-A was expressed at high mRNA and protein levels in inflamed ears but that expression was increased only at the protein level in activated LNs. Inflammation-induced lymphangiogenesis in LNs was independent of the presence of nodal B lymphocytes, as shown in B cell-deficient mice. Our data reveal that chronic inflammation actively induces lymphangiogenesis in LNs, which is controlled remotely, by lymphangiogenic factors produced at the site of inflammation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Y. Lim, J. M. Rutkowski, J. Helft, S. T. Reddy, M. A. Swartz, G. J. Randolph, and V. Angeli
Hypercholesterolemic Mice Exhibit Lymphatic Vessel Dysfunction and Degeneration
Am. J. Pathol.,
September 1, 2009;
175(3):
1328 - 1337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Kataru, K. Jung, C. Jang, H. Yang, R. A. Schwendener, J. E. Baik, S. H. Han, K. Alitalo, and G. Y. Koh
Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution
Blood,
May 28, 2009;
113(22):
5650 - 5659.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Ruiz de Almodovar, D. Lambrechts, M. Mazzone, and P. Carmeliet
Role and Therapeutic Potential of VEGF in the Nervous System
Physiol Rev,
April 1, 2009;
89(2):
607 - 648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Spinella, E. Garrafa, V. Di Castro, L. Rosano, M. R. Nicotra, A. Caruso, P. G. Natali, and A. Bagnato
Endothelin-1 Stimulates Lymphatic Endothelial Cells and Lymphatic Vessels to Grow and Invade
Cancer Res.,
March 15, 2009;
69(6):
2669 - 2676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Saban, M. R. Saban, J. Maier, B. Fowler, M. Tengowski, C. A. Davis, X.-R. Wu, D. J. Culkin, P. Hauser, J. Backer, et al.
Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients
Am J Physiol Renal Physiol,
December 1, 2008;
295(6):
F1613 - F1623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chyou, E. H. Ekland, A. C. Carpenter, T.-C. J. Tzeng, S. Tian, M. Michaud, J. A. Madri, and T. T. Lu
Fibroblast-Type Reticular Stromal Cells Regulate the Lymph Node Vasculature
J. Immunol.,
September 15, 2008;
181(6):
3887 - 3896.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Saban, J. M. Backer, M. V. Backer, J. Maier, B. Fowler, C. A. Davis, C. Simpson, X.-R. Wu, L. Birder, M. R. Freeman, et al.
VEGF receptors and neuropilins are expressed in the urothelial and neuronal cells in normal mouse urinary bladder and are upregulated in inflammation
Am J Physiol Renal Physiol,
July 1, 2008;
295(1):
F60 - F72.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Halin, H. Fahrngruber, J. G. Meingassner, G. Bold, A. Littlewood-Evans, A. Stuetz, and M. Detmar
Inhibition of Chronic and Acute Skin Inflammation by Treatment with a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor
Am. J. Pathol.,
July 1, 2008;
173(1):
265 - 277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Oka, C. Iwata, H. I. Suzuki, K. Kiyono, Y. Morishita, T. Watabe, A. Komuro, M. R. Kano, and K. Miyazono
Inhibition of endogenous TGF-{beta} signaling enhances lymphangiogenesis
Blood,
May 1, 2008;
111(9):
4571 - 4579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yu, X. Wu, Z. Cheng, C. V. Lee, J. LeCouter, C. Campa, G. Fuh, H. Lowman, and N. Ferrara
Interaction between Bevacizumab and Murine VEGF-A: A Reassessment
Invest. Ophthalmol. Vis. Sci.,
February 1, 2008;
49(2):
522 - 527.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|